PSS22 - Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom
| Autor: | Leteneux, C., Claxton, L., Malcolm, W.A., Taylor, M., Rathi, H. |
|---|---|
| Zdroj: | In Value in Health November 2013 16(7):A505-A505 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect